| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyotrophic Lateral Sclerosis | 126 | 2026 | 510 | 17.930 |
Why?
|
| Superoxide Dismutase | 47 | 2025 | 221 | 5.450 |
Why?
|
| Superoxide Dismutase-1 | 46 | 2026 | 144 | 4.130 |
Why?
|
| Mutation | 60 | 2024 | 2658 | 3.600 |
Why?
|
| Motor Neurons | 35 | 2025 | 213 | 3.070 |
Why?
|
| C9orf72 Protein | 18 | 2023 | 114 | 2.630 |
Why?
|
| Frontotemporal Dementia | 12 | 2026 | 157 | 2.110 |
Why?
|
| Cytoskeletal Proteins | 10 | 2025 | 204 | 1.840 |
Why?
|
| MicroRNAs | 9 | 2023 | 704 | 1.600 |
Why?
|
| Genetic Predisposition to Disease | 27 | 2021 | 733 | 1.590 |
Why?
|
| Mice, Transgenic | 37 | 2026 | 1285 | 1.520 |
Why?
|
| Oligonucleotides, Antisense | 7 | 2025 | 149 | 1.480 |
Why?
|
| Animals | 104 | 2026 | 21292 | 1.450 |
Why?
|
| DNA Repeat Expansion | 8 | 2023 | 58 | 1.440 |
Why?
|
| Genetic Therapy | 11 | 2024 | 821 | 1.420 |
Why?
|
| Mice | 76 | 2026 | 11085 | 1.360 |
Why?
|
| Humans | 165 | 2026 | 64729 | 1.350 |
Why?
|
| Disease Models, Animal | 29 | 2026 | 2270 | 1.230 |
Why?
|
| Motor Neuron Disease | 9 | 2015 | 28 | 1.180 |
Why?
|
| Armadillo Domain Proteins | 6 | 2025 | 27 | 1.140 |
Why?
|
| Polymorphism, Single Nucleotide | 15 | 2017 | 506 | 1.070 |
Why?
|
| Spinal Cord | 15 | 2024 | 207 | 1.040 |
Why?
|
| Nervous System Diseases | 4 | 2024 | 107 | 1.010 |
Why?
|
| Axonal Transport | 4 | 2022 | 32 | 1.010 |
Why?
|
| Muscle Proteins | 6 | 2010 | 117 | 1.010 |
Why?
|
| RNA-Binding Protein FUS | 7 | 2025 | 53 | 0.990 |
Why?
|
| Axons | 8 | 2023 | 123 | 0.980 |
Why?
|
| Membrane Proteins | 9 | 2019 | 922 | 0.960 |
Why?
|
| Dysferlin | 7 | 2019 | 12 | 0.940 |
Why?
|
| Genome-Wide Association Study | 12 | 2021 | 358 | 0.940 |
Why?
|
| Oligonucleotides | 3 | 2025 | 226 | 0.920 |
Why?
|
| Neurons | 18 | 2023 | 939 | 0.860 |
Why?
|
| Nerve Growth Factors | 2 | 2022 | 28 | 0.790 |
Why?
|
| Muscle, Skeletal | 6 | 2014 | 764 | 0.790 |
Why?
|
| Profilins | 6 | 2022 | 44 | 0.770 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2017 | 439 | 0.770 |
Why?
|
| Protein Disulfide-Isomerases | 3 | 2021 | 15 | 0.750 |
Why?
|
| Lung | 6 | 2022 | 965 | 0.740 |
Why?
|
| Phenotype | 12 | 2024 | 1231 | 0.740 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 6 | 2021 | 11 | 0.730 |
Why?
|
| Male | 71 | 2026 | 30790 | 0.730 |
Why?
|
| Introns | 2 | 2021 | 111 | 0.730 |
Why?
|
| Promoter Regions, Genetic | 7 | 2012 | 682 | 0.720 |
Why?
|
| Lung Diseases | 3 | 2022 | 182 | 0.720 |
Why?
|
| Muscular Dystrophies | 4 | 2007 | 11 | 0.710 |
Why?
|
| Asthma | 5 | 2016 | 472 | 0.670 |
Why?
|
| Genetic Association Studies | 8 | 2018 | 119 | 0.670 |
Why?
|
| Proteins | 8 | 2024 | 763 | 0.660 |
Why?
|
| Female | 67 | 2025 | 33739 | 0.650 |
Why?
|
| Serine C-Palmitoyltransferase | 7 | 2021 | 17 | 0.640 |
Why?
|
| Genetic Variation | 8 | 2021 | 391 | 0.620 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2019 | 39 | 0.610 |
Why?
|
| Tomography, Optical Coherence | 1 | 2022 | 235 | 0.600 |
Why?
|
| Dipeptides | 4 | 2023 | 68 | 0.600 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2018 | 156 | 0.590 |
Why?
|
| Gene Silencing | 6 | 2025 | 418 | 0.590 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2019 | 22 | 0.580 |
Why?
|
| Biomarkers | 9 | 2024 | 1465 | 0.580 |
Why?
|
| Neuromuscular Junction | 3 | 2018 | 78 | 0.570 |
Why?
|
| Nerve Degeneration | 8 | 2021 | 68 | 0.570 |
Why?
|
| Middle Aged | 42 | 2025 | 18106 | 0.560 |
Why?
|
| Mutation, Missense | 7 | 2021 | 188 | 0.530 |
Why?
|
| Genotype | 11 | 2017 | 670 | 0.520 |
Why?
|
| Electrophysiological Phenomena | 2 | 2016 | 22 | 0.510 |
Why?
|
| RNA, Small Interfering | 5 | 2025 | 969 | 0.500 |
Why?
|
| Bulbar Palsy, Progressive | 2 | 2017 | 5 | 0.500 |
Why?
|
| Brain Injuries, Traumatic | 3 | 2025 | 93 | 0.500 |
Why?
|
| Dependovirus | 8 | 2022 | 735 | 0.500 |
Why?
|
| NAV1.3 Voltage-Gated Sodium Channel | 1 | 2016 | 2 | 0.490 |
Why?
|
| CRISPR-Cas Systems | 3 | 2022 | 367 | 0.490 |
Why?
|
| Health Personnel | 1 | 2020 | 385 | 0.490 |
Why?
|
| Vital Capacity | 4 | 2021 | 121 | 0.480 |
Why?
|
| Disease Progression | 13 | 2025 | 1210 | 0.480 |
Why?
|
| Endogenous Retroviruses | 1 | 2015 | 12 | 0.460 |
Why?
|
| Fibroblasts | 4 | 2021 | 414 | 0.450 |
Why?
|
| Adult | 34 | 2025 | 17230 | 0.440 |
Why?
|
| Haplotypes | 5 | 2009 | 134 | 0.430 |
Why?
|
| Brain | 13 | 2021 | 1594 | 0.420 |
Why?
|
| Recovery of Function | 1 | 2016 | 289 | 0.420 |
Why?
|
| Sarcolemma | 2 | 2004 | 10 | 0.420 |
Why?
|
| Brain Injuries | 1 | 2016 | 141 | 0.420 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2014 | 7 | 0.420 |
Why?
|
| DNA-Binding Proteins | 8 | 2023 | 1220 | 0.410 |
Why?
|
| Aged | 31 | 2025 | 14834 | 0.410 |
Why?
|
| Gene Editing | 1 | 2018 | 327 | 0.410 |
Why?
|
| DNA Mutational Analysis | 8 | 2019 | 197 | 0.390 |
Why?
|
| Bariatric Surgery | 1 | 2014 | 65 | 0.390 |
Why?
|
| Neurofilament Proteins | 3 | 2024 | 25 | 0.390 |
Why?
|
| Carrier Proteins | 4 | 2012 | 718 | 0.380 |
Why?
|
| Aryldialkylphosphatase | 2 | 2010 | 19 | 0.370 |
Why?
|
| Nerve Tissue Proteins | 6 | 2015 | 430 | 0.360 |
Why?
|
| Age of Onset | 9 | 2019 | 173 | 0.360 |
Why?
|
| Enzyme Inhibitors | 2 | 2021 | 364 | 0.360 |
Why?
|
| Cell Cycle Proteins | 3 | 2018 | 403 | 0.360 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2012 | 34 | 0.360 |
Why?
|
| Weight Loss | 1 | 2014 | 274 | 0.360 |
Why?
|
| Double-Blind Method | 4 | 2024 | 740 | 0.350 |
Why?
|
| Genetic Vectors | 4 | 2021 | 903 | 0.350 |
Why?
|
| RNA Interference | 4 | 2025 | 640 | 0.350 |
Why?
|
| Epilepsy | 2 | 2023 | 112 | 0.340 |
Why?
|
| Annexins | 2 | 2017 | 8 | 0.340 |
Why?
|
| Genes, Dominant | 4 | 2021 | 56 | 0.340 |
Why?
|
| Vanadium | 1 | 2010 | 4 | 0.330 |
Why?
|
| Respiratory System | 2 | 2008 | 47 | 0.330 |
Why?
|
| Proteostasis Deficiencies | 1 | 2010 | 6 | 0.330 |
Why?
|
| Aluminum | 1 | 2010 | 14 | 0.330 |
Why?
|
| Manganese | 1 | 2010 | 20 | 0.330 |
Why?
|
| Brain Concussion | 2 | 2023 | 37 | 0.330 |
Why?
|
| Aging | 5 | 2018 | 761 | 0.330 |
Why?
|
| Transplantation, Autologous | 2 | 2022 | 128 | 0.330 |
Why?
|
| Neuroprotective Agents | 3 | 2006 | 78 | 0.330 |
Why?
|
| Amino Acid Sequence | 13 | 2021 | 1592 | 0.320 |
Why?
|
| Magnesium | 1 | 2010 | 54 | 0.320 |
Why?
|
| Sphingolipids | 4 | 2021 | 24 | 0.320 |
Why?
|
| Hair | 1 | 2010 | 81 | 0.310 |
Why?
|
| Gene Expression | 6 | 2018 | 856 | 0.310 |
Why?
|
| Cell Line | 13 | 2024 | 2036 | 0.310 |
Why?
|
| Methacholine Chloride | 2 | 2016 | 23 | 0.310 |
Why?
|
| Muscular Diseases | 1 | 2010 | 50 | 0.310 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2006 | 95 | 0.310 |
Why?
|
| HIV Infections | 1 | 2016 | 951 | 0.310 |
Why?
|
| RNA Splicing | 3 | 2021 | 164 | 0.310 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2022 | 159 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2010 | 104 | 0.300 |
Why?
|
| Bronchodilator Agents | 2 | 2022 | 121 | 0.300 |
Why?
|
| Cell Survival | 9 | 2014 | 581 | 0.290 |
Why?
|
| Gene Expression Regulation | 7 | 2021 | 1633 | 0.290 |
Why?
|
| Cells, Cultured | 11 | 2021 | 2188 | 0.290 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 907 | 0.290 |
Why?
|
| Immunohistochemistry | 10 | 2016 | 897 | 0.290 |
Why?
|
| Cellular Reprogramming | 1 | 2008 | 41 | 0.280 |
Why?
|
| Injections, Spinal | 4 | 2025 | 45 | 0.280 |
Why?
|
| Neurodegenerative Diseases | 3 | 2023 | 148 | 0.280 |
Why?
|
| Sequence Deletion | 1 | 2008 | 115 | 0.280 |
Why?
|
| Tetanus Toxin | 4 | 2009 | 8 | 0.280 |
Why?
|
| Golgi Apparatus | 1 | 2008 | 65 | 0.270 |
Why?
|
| Cohort Studies | 8 | 2018 | 2603 | 0.270 |
Why?
|
| Recombinant Proteins | 5 | 2021 | 710 | 0.270 |
Why?
|
| Skin | 3 | 2023 | 414 | 0.270 |
Why?
|
| Pluripotent Stem Cells | 1 | 2008 | 72 | 0.270 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 703 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 12 | 2026 | 3460 | 0.270 |
Why?
|
| Neurotoxins | 3 | 2013 | 21 | 0.270 |
Why?
|
| Young Adult | 12 | 2021 | 4771 | 0.260 |
Why?
|
| Bronchoconstriction | 1 | 2007 | 9 | 0.260 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2018 | 497 | 0.260 |
Why?
|
| Vesicular Transport Proteins | 1 | 2008 | 117 | 0.260 |
Why?
|
| Lidocaine | 1 | 2007 | 33 | 0.260 |
Why?
|
| Exons | 3 | 2021 | 204 | 0.260 |
Why?
|
| Muscle Hypotonia | 1 | 2006 | 7 | 0.250 |
Why?
|
| Quadriceps Muscle | 1 | 2006 | 14 | 0.250 |
Why?
|
| Rats | 9 | 2024 | 1996 | 0.250 |
Why?
|
| Laminin | 1 | 2006 | 81 | 0.250 |
Why?
|
| Mutant Proteins | 4 | 2012 | 105 | 0.250 |
Why?
|
| Inhalation | 1 | 2006 | 11 | 0.250 |
Why?
|
| Histone Deacetylase 6 | 1 | 2026 | 8 | 0.250 |
Why?
|
| Cell Differentiation | 3 | 2014 | 1381 | 0.240 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 2 | 2006 | 4 | 0.240 |
Why?
|
| Polymorphism, Genetic | 6 | 2012 | 198 | 0.240 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2026 | 37 | 0.240 |
Why?
|
| Pedigree | 9 | 2021 | 193 | 0.240 |
Why?
|
| Obesity | 1 | 2014 | 1263 | 0.240 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2006 | 95 | 0.240 |
Why?
|
| Histone Acetyltransferases | 2 | 2021 | 59 | 0.240 |
Why?
|
| Distal Myopathies | 2 | 2019 | 6 | 0.240 |
Why?
|
| Endoplasmic Reticulum | 2 | 2021 | 178 | 0.240 |
Why?
|
| Peptide Fragments | 4 | 2009 | 416 | 0.240 |
Why?
|
| Survival Analysis | 2 | 2017 | 575 | 0.230 |
Why?
|
| Forced Expiratory Volume | 4 | 2022 | 211 | 0.230 |
Why?
|
| Anterior Horn Cells | 2 | 2006 | 6 | 0.230 |
Why?
|
| Guanine Nucleotide Exchange Factors | 3 | 2015 | 62 | 0.230 |
Why?
|
| Cell Death | 3 | 2013 | 288 | 0.230 |
Why?
|
| Sheep | 2 | 2024 | 189 | 0.230 |
Why?
|
| Ceftriaxone | 1 | 2005 | 19 | 0.220 |
Why?
|
| Mitochondria | 2 | 2010 | 399 | 0.220 |
Why?
|
| Gloves, Surgical | 1 | 2004 | 3 | 0.220 |
Why?
|
| Sialyltransferases | 2 | 2023 | 21 | 0.220 |
Why?
|
| Latex Hypersensitivity | 1 | 2004 | 2 | 0.220 |
Why?
|
| Latex | 1 | 2004 | 5 | 0.220 |
Why?
|
| Neuroblastoma | 2 | 2006 | 54 | 0.220 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 3 | 2009 | 7 | 0.220 |
Why?
|
| Mice, Knockout | 6 | 2025 | 2150 | 0.220 |
Why?
|
| Linkage Disequilibrium | 4 | 2012 | 47 | 0.210 |
Why?
|
| Proteostasis | 2 | 2021 | 11 | 0.210 |
Why?
|
| Wallerian Degeneration | 2 | 2016 | 8 | 0.210 |
Why?
|
| Allergens | 1 | 2004 | 55 | 0.210 |
Why?
|
| RNA, Messenger | 6 | 2021 | 1572 | 0.210 |
Why?
|
| Protein Aggregation, Pathological | 4 | 2018 | 20 | 0.210 |
Why?
|
| Cysteine | 3 | 2024 | 107 | 0.210 |
Why?
|
| Cyclosporine | 1 | 2004 | 77 | 0.210 |
Why?
|
| Pick Disease of the Brain | 1 | 2023 | 6 | 0.210 |
Why?
|
| Annexin A1 | 1 | 2003 | 2 | 0.210 |
Why?
|
| Protein Structure, Tertiary | 7 | 2018 | 677 | 0.200 |
Why?
|
| Annexin A2 | 1 | 2003 | 7 | 0.200 |
Why?
|
| Sequence Analysis, DNA | 5 | 2016 | 413 | 0.200 |
Why?
|
| Species Specificity | 1 | 2024 | 339 | 0.200 |
Why?
|
| Fetal Blood | 1 | 2004 | 73 | 0.200 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2003 | 1 | 0.200 |
Why?
|
| Citrullination | 1 | 2024 | 38 | 0.200 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2023 | 6 | 0.200 |
Why?
|
| Endoplasmic Reticulum Stress | 3 | 2018 | 51 | 0.200 |
Why?
|
| Calcium-Binding Proteins | 2 | 2016 | 94 | 0.200 |
Why?
|
| Protein Folding | 4 | 2022 | 269 | 0.200 |
Why?
|
| Blotting, Western | 4 | 2012 | 610 | 0.200 |
Why?
|
| Biopsy | 2 | 2022 | 454 | 0.190 |
Why?
|
| Aged, 80 and over | 11 | 2018 | 5562 | 0.190 |
Why?
|
| Stereoisomerism | 2 | 2021 | 52 | 0.190 |
Why?
|
| Transfection | 4 | 2012 | 700 | 0.190 |
Why?
|
| Spastic Paraplegia, Hereditary | 2 | 2021 | 13 | 0.190 |
Why?
|
| Single-Domain Antibodies | 1 | 2022 | 21 | 0.190 |
Why?
|
| Syndrome | 1 | 2023 | 178 | 0.190 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 195 | 0.190 |
Why?
|
| Exome | 4 | 2016 | 69 | 0.190 |
Why?
|
| Molecular Sequence Data | 7 | 2015 | 1984 | 0.190 |
Why?
|
| Interleukin-18 Receptor beta Subunit | 1 | 2022 | 2 | 0.190 |
Why?
|
| Emphysema | 1 | 2022 | 38 | 0.180 |
Why?
|
| Tetanus Toxoid | 1 | 2022 | 14 | 0.180 |
Why?
|
| Wound Healing | 1 | 2003 | 193 | 0.180 |
Why?
|
| Trans-Activators | 2 | 2016 | 321 | 0.180 |
Why?
|
| Cytoskeleton | 3 | 2021 | 140 | 0.180 |
Why?
|
| Longitudinal Studies | 4 | 2020 | 1274 | 0.180 |
Why?
|
| Microsatellite Repeats | 3 | 2021 | 42 | 0.180 |
Why?
|
| Pulmonary Emphysema | 1 | 2022 | 109 | 0.180 |
Why?
|
| Neuroglia | 2 | 2015 | 80 | 0.180 |
Why?
|
| Actins | 3 | 2019 | 262 | 0.180 |
Why?
|
| Myelin Proteins | 2 | 2024 | 30 | 0.180 |
Why?
|
| Muscular Atrophy | 2 | 2019 | 29 | 0.180 |
Why?
|
| Alleles | 4 | 2021 | 452 | 0.170 |
Why?
|
| Fatal Outcome | 2 | 2020 | 121 | 0.170 |
Why?
|
| Parkinsonian Disorders | 1 | 2021 | 15 | 0.170 |
Why?
|
| Tay-Sachs Disease | 1 | 2022 | 52 | 0.170 |
Why?
|
| Glutamates | 1 | 2021 | 13 | 0.170 |
Why?
|
| Astrocytes | 3 | 2022 | 121 | 0.170 |
Why?
|
| Dystrophin | 3 | 2006 | 30 | 0.170 |
Why?
|
| Protein Binding | 7 | 2018 | 1640 | 0.170 |
Why?
|
| Meningoencephalitis | 1 | 2020 | 9 | 0.160 |
Why?
|
| NIMA-Related Kinase 1 | 2 | 2019 | 4 | 0.160 |
Why?
|
| Spirometry | 2 | 2020 | 113 | 0.160 |
Why?
|
| Proof of Concept Study | 1 | 2020 | 39 | 0.160 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 119 | 0.160 |
Why?
|
| Immunosuppressive Agents | 2 | 2018 | 380 | 0.160 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2010 | 11 | 0.160 |
Why?
|
| Dementia | 2 | 2018 | 272 | 0.160 |
Why?
|
| Neuropathology | 1 | 2019 | 3 | 0.160 |
Why?
|
| Binding Sites | 4 | 2009 | 920 | 0.160 |
Why?
|
| Arsenic | 1 | 2020 | 13 | 0.160 |
Why?
|
| Personal Satisfaction | 1 | 2020 | 83 | 0.160 |
Why?
|
| Adolescent | 9 | 2021 | 6291 | 0.160 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2020 | 34 | 0.160 |
Why?
|
| DNA Copy Number Variations | 2 | 2010 | 72 | 0.160 |
Why?
|
| Respiration Disorders | 1 | 2020 | 26 | 0.160 |
Why?
|
| PC12 Cells | 2 | 2012 | 27 | 0.160 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2016 | 364 | 0.160 |
Why?
|
| Indians, North American | 1 | 2020 | 29 | 0.160 |
Why?
|
| Nuclear Pore | 1 | 2019 | 23 | 0.150 |
Why?
|
| Transduction, Genetic | 2 | 2013 | 242 | 0.150 |
Why?
|
| Environmental Exposure | 3 | 2020 | 223 | 0.150 |
Why?
|
| Genetic Testing | 3 | 2013 | 140 | 0.150 |
Why?
|
| Point Mutation | 4 | 2011 | 168 | 0.150 |
Why?
|
| RNA | 4 | 2022 | 426 | 0.150 |
Why?
|
| Voltage-Gated Sodium Channel Blockers | 2 | 2016 | 4 | 0.150 |
Why?
|
| Quantitative Trait Loci | 3 | 2021 | 79 | 0.150 |
Why?
|
| Structure-Activity Relationship | 2 | 2012 | 355 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2017 | 414 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 801 | 0.140 |
Why?
|
| Case-Control Studies | 8 | 2016 | 1135 | 0.140 |
Why?
|
| Sodium | 2 | 2016 | 60 | 0.140 |
Why?
|
| Cortical Spreading Depression | 1 | 2018 | 9 | 0.140 |
Why?
|
| Medical Errors | 1 | 2020 | 198 | 0.140 |
Why?
|
| Body Temperature Regulation | 1 | 2018 | 22 | 0.140 |
Why?
|
| Central Nervous System | 4 | 2024 | 200 | 0.140 |
Why?
|
| Transcription Factors | 2 | 2021 | 1549 | 0.140 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 267 | 0.140 |
Why?
|
| Base Sequence | 4 | 2012 | 1326 | 0.140 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 24 | 0.140 |
Why?
|
| Action Potentials | 2 | 2013 | 112 | 0.140 |
Why?
|
| Drosophila Proteins | 2 | 2015 | 757 | 0.140 |
Why?
|
| Adenoidectomy | 1 | 2017 | 7 | 0.140 |
Why?
|
| Nucleic Acids | 1 | 2019 | 60 | 0.140 |
Why?
|
| Tonsillectomy | 1 | 2017 | 12 | 0.140 |
Why?
|
| Risk Factors | 8 | 2021 | 5393 | 0.130 |
Why?
|
| Oxidation-Reduction | 3 | 2018 | 323 | 0.130 |
Why?
|
| Proteolysis | 2 | 2016 | 154 | 0.130 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 405 | 0.130 |
Why?
|
| Ubiquitination | 2 | 2015 | 117 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 2 | 2018 | 875 | 0.130 |
Why?
|
| Chromosome Mapping | 4 | 2016 | 295 | 0.130 |
Why?
|
| Dinucleotide Repeats | 1 | 2017 | 7 | 0.130 |
Why?
|
| DNA Primers | 4 | 2012 | 300 | 0.130 |
Why?
|
| HeLa Cells | 2 | 2012 | 540 | 0.130 |
Why?
|
| Infusions, Intravenous | 2 | 2008 | 175 | 0.130 |
Why?
|
| Switzerland | 1 | 2017 | 17 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 4 | 2018 | 374 | 0.130 |
Why?
|
| Amino Acid Substitution | 5 | 2017 | 237 | 0.130 |
Why?
|
| Software | 1 | 2020 | 392 | 0.130 |
Why?
|
| In Vitro Techniques | 2 | 2015 | 493 | 0.130 |
Why?
|
| Neural Conduction | 2 | 2015 | 32 | 0.130 |
Why?
|
| Sweden | 1 | 2017 | 63 | 0.130 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2017 | 62 | 0.130 |
Why?
|
| Tidal Volume | 1 | 2016 | 41 | 0.130 |
Why?
|
| Munc18 Proteins | 1 | 2016 | 12 | 0.120 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2016 | 33 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 3 | 2012 | 512 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2015 | 269 | 0.120 |
Why?
|
| Mexiletine | 1 | 2016 | 1 | 0.120 |
Why?
|
| Autophagy-Related Proteins | 2 | 2015 | 16 | 0.120 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2016 | 6 | 0.120 |
Why?
|
| Caveolin 3 | 2 | 2007 | 3 | 0.120 |
Why?
|
| Cell Count | 3 | 2006 | 129 | 0.120 |
Why?
|
| Tuberculosis | 1 | 2020 | 303 | 0.120 |
Why?
|
| Xenopus laevis | 1 | 2016 | 71 | 0.120 |
Why?
|
| Cyclins | 1 | 2016 | 41 | 0.120 |
Why?
|
| Cytokines | 1 | 2020 | 951 | 0.120 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2015 | 19 | 0.120 |
Why?
|
| Pandemics | 1 | 2021 | 669 | 0.120 |
Why?
|
| Amyloid beta-Peptides | 2 | 2016 | 317 | 0.120 |
Why?
|
| Corpus Callosum | 1 | 2016 | 41 | 0.120 |
Why?
|
| Oxidative Stress | 2 | 2015 | 317 | 0.110 |
Why?
|
| Apoptosis | 5 | 2012 | 1094 | 0.110 |
Why?
|
| Inflammation | 2 | 2015 | 1185 | 0.110 |
Why?
|
| Protein Transport | 4 | 2017 | 409 | 0.110 |
Why?
|
| Dogs | 2 | 2024 | 317 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2016 | 1656 | 0.110 |
Why?
|
| Neuromuscular Diseases | 1 | 2015 | 23 | 0.110 |
Why?
|
| Calcium | 3 | 2013 | 583 | 0.110 |
Why?
|
| Neurology | 1 | 2015 | 44 | 0.110 |
Why?
|
| G-Quadruplexes | 1 | 2014 | 6 | 0.110 |
Why?
|
| Gene Dosage | 2 | 2016 | 70 | 0.110 |
Why?
|
| Child | 5 | 2021 | 4599 | 0.110 |
Why?
|
| Circadian Rhythm | 1 | 2018 | 390 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 129 | 0.110 |
Why?
|
| Tubulin | 1 | 2014 | 73 | 0.110 |
Why?
|
| Models, Biological | 4 | 2010 | 1203 | 0.110 |
Why?
|
| Nervous System | 2 | 2016 | 71 | 0.110 |
Why?
|
| Copper | 2 | 2007 | 56 | 0.100 |
Why?
|
| Global Health | 1 | 2015 | 180 | 0.100 |
Why?
|
| Neuregulins | 1 | 2013 | 9 | 0.100 |
Why?
|
| Serine | 2 | 2011 | 90 | 0.100 |
Why?
|
| Career Choice | 1 | 2015 | 132 | 0.100 |
Why?
|
| Liver | 3 | 2018 | 867 | 0.100 |
Why?
|
| Time Factors | 3 | 2008 | 3745 | 0.100 |
Why?
|
| Chronic Disease | 1 | 2016 | 745 | 0.100 |
Why?
|
| Models, Molecular | 4 | 2012 | 1157 | 0.100 |
Why?
|
| Age Factors | 2 | 2015 | 1580 | 0.100 |
Why?
|
| Botulinum Toxins | 1 | 2013 | 5 | 0.100 |
Why?
|
| Syntaxin 1 | 1 | 2013 | 3 | 0.100 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2013 | 10 | 0.100 |
Why?
|
| Prognosis | 3 | 2020 | 1770 | 0.100 |
Why?
|
| ErbB Receptors | 1 | 2013 | 127 | 0.100 |
Why?
|
| Survival Rate | 2 | 2006 | 847 | 0.100 |
Why?
|
| Ribonucleases | 1 | 2012 | 33 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 150 | 0.090 |
Why?
|
| Treatment Outcome | 5 | 2025 | 5758 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2012 | 23 | 0.090 |
Why?
|
| Mass Spectrometry | 2 | 2013 | 295 | 0.090 |
Why?
|
| Neuronal Outgrowth | 2 | 2022 | 9 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2004 | 251 | 0.090 |
Why?
|
| Muscle Weakness | 2 | 2010 | 33 | 0.090 |
Why?
|
| Axotomy | 4 | 2018 | 8 | 0.090 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2012 | 3 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 129 | 0.090 |
Why?
|
| Neurogenesis | 1 | 2012 | 63 | 0.090 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 112 | 0.090 |
Why?
|
| Charcot-Marie-Tooth Disease | 2 | 2015 | 6 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2015 | 348 | 0.090 |
Why?
|
| Sphingosine | 1 | 2011 | 20 | 0.090 |
Why?
|
| Exocytosis | 2 | 2013 | 61 | 0.090 |
Why?
|
| Zebrafish | 4 | 2021 | 369 | 0.090 |
Why?
|
| T-Lymphocytes | 2 | 2008 | 1007 | 0.090 |
Why?
|
| Contractile Proteins | 1 | 2011 | 14 | 0.090 |
Why?
|
| Family Health | 2 | 2016 | 68 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 447 | 0.090 |
Why?
|
| Cell Membrane | 3 | 2013 | 507 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2012 | 792 | 0.080 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 226 | 0.080 |
Why?
|
| Autoantibodies | 1 | 2011 | 184 | 0.080 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2010 | 34 | 0.080 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2010 | 10 | 0.080 |
Why?
|
| Epitope Mapping | 1 | 2010 | 52 | 0.080 |
Why?
|
| Mice, Mutant Strains | 2 | 2017 | 302 | 0.080 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 556 | 0.080 |
Why?
|
| Basophils | 1 | 2010 | 15 | 0.080 |
Why?
|
| Inclusion Bodies | 1 | 2010 | 17 | 0.080 |
Why?
|
| Esterases | 1 | 2010 | 13 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2011 | 1001 | 0.080 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 115 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 2017 | 1309 | 0.080 |
Why?
|
| Analysis of Variance | 3 | 2006 | 604 | 0.080 |
Why?
|
| Hospitalization | 1 | 2017 | 1384 | 0.080 |
Why?
|
| Potassium Channels | 1 | 2010 | 55 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2016 | 23 | 0.080 |
Why?
|
| Lameness, Animal | 1 | 2010 | 6 | 0.080 |
Why?
|
| Kyphosis | 1 | 2010 | 6 | 0.080 |
Why?
|
| Hypokalemic Periodic Paralysis | 1 | 2010 | 2 | 0.080 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2010 | 5 | 0.080 |
Why?
|
| Electric Stimulation | 2 | 2008 | 139 | 0.080 |
Why?
|
| Muscle Denervation | 1 | 2009 | 4 | 0.080 |
Why?
|
| HEK293 Cells | 3 | 2021 | 616 | 0.080 |
Why?
|
| Muscle Cells | 1 | 2009 | 28 | 0.080 |
Why?
|
| Protein Biosynthesis | 2 | 2010 | 331 | 0.080 |
Why?
|
| Animals, Newborn | 4 | 2016 | 241 | 0.080 |
Why?
|
| tau Proteins | 2 | 2009 | 207 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2017 | 246 | 0.080 |
Why?
|
| Myostatin | 1 | 2009 | 19 | 0.080 |
Why?
|
| Behavior, Animal | 2 | 2016 | 236 | 0.080 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2011 | 449 | 0.080 |
Why?
|
| Gene Frequency | 2 | 2009 | 122 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2006 | 989 | 0.080 |
Why?
|
| Acyl Coenzyme A | 1 | 2009 | 9 | 0.080 |
Why?
|
| Molecular Chaperones | 1 | 2010 | 100 | 0.080 |
Why?
|
| DNA Helicases | 1 | 2011 | 198 | 0.080 |
Why?
|
| Crystallography, X-Ray | 1 | 2010 | 419 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 66 | 0.080 |
Why?
|
| Genes, Recessive | 1 | 2009 | 51 | 0.070 |
Why?
|
| Genetic Loci | 1 | 2009 | 116 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2016 | 851 | 0.070 |
Why?
|
| Animals, Genetically Modified | 3 | 2016 | 310 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2009 | 173 | 0.070 |
Why?
|
| United States | 5 | 2020 | 8041 | 0.070 |
Why?
|
| Motor Activity | 2 | 2024 | 347 | 0.070 |
Why?
|
| Superior Colliculi | 1 | 2008 | 12 | 0.070 |
Why?
|
| Cytoprotection | 1 | 2008 | 18 | 0.070 |
Why?
|
| Brain Stem | 1 | 2008 | 27 | 0.070 |
Why?
|
| Scotland | 1 | 2008 | 9 | 0.070 |
Why?
|
| Quebec | 1 | 2008 | 14 | 0.070 |
Why?
|
| Ireland | 1 | 2008 | 17 | 0.070 |
Why?
|
| Hydroxylamines | 1 | 2008 | 7 | 0.070 |
Why?
|
| Sp1 Transcription Factor | 1 | 2008 | 21 | 0.070 |
Why?
|
| Sequence Analysis, RNA | 1 | 2009 | 178 | 0.070 |
Why?
|
| Signal Transduction | 4 | 2013 | 3147 | 0.070 |
Why?
|
| Phosphorylation | 3 | 2018 | 960 | 0.070 |
Why?
|
| RNA Splice Sites | 1 | 2008 | 22 | 0.070 |
Why?
|
| Culture Media, Conditioned | 2 | 2022 | 52 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2008 | 129 | 0.070 |
Why?
|
| Homozygote | 1 | 2008 | 122 | 0.070 |
Why?
|
| Multigene Family | 1 | 2008 | 106 | 0.070 |
Why?
|
| Benzodiazepinones | 1 | 2008 | 2 | 0.070 |
Why?
|
| Convulsants | 1 | 2008 | 7 | 0.070 |
Why?
|
| Birth Order | 1 | 2007 | 2 | 0.070 |
Why?
|
| Receptors, GABA | 1 | 2008 | 13 | 0.070 |
Why?
|
| Glutamic Acid | 2 | 2006 | 103 | 0.070 |
Why?
|
| CHO Cells | 2 | 2005 | 191 | 0.070 |
Why?
|
| DNA Methylation | 2 | 2022 | 301 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2010 | 209 | 0.070 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2007 | 4 | 0.070 |
Why?
|
| Nerve Regeneration | 1 | 2008 | 37 | 0.070 |
Why?
|
| Caspases | 2 | 2006 | 176 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2009 | 426 | 0.070 |
Why?
|
| Protein Isoforms | 2 | 2007 | 202 | 0.070 |
Why?
|
| Nerve Net | 1 | 2008 | 101 | 0.070 |
Why?
|
| Cricetinae | 2 | 2005 | 369 | 0.070 |
Why?
|
| Actinin | 1 | 2007 | 11 | 0.070 |
Why?
|
| Radiography | 2 | 2006 | 556 | 0.070 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 156 | 0.070 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2009 | 116 | 0.060 |
Why?
|
| Autophagy | 1 | 2009 | 232 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 194 | 0.060 |
Why?
|
| Dystrophin-Associated Protein Complex | 1 | 2006 | 1 | 0.060 |
Why?
|
| Transcription Factor TFIIIA | 2 | 2018 | 7 | 0.060 |
Why?
|
| Creatine Kinase | 1 | 2006 | 42 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2008 | 497 | 0.060 |
Why?
|
| Gait Ataxia | 1 | 2006 | 3 | 0.060 |
Why?
|
| Sciatic Nerve | 3 | 2012 | 29 | 0.060 |
Why?
|
| Netherlands | 2 | 2016 | 25 | 0.060 |
Why?
|
| Myelin P0 Protein | 1 | 2006 | 1 | 0.060 |
Why?
|
| Respiratory Function Tests | 1 | 2007 | 194 | 0.060 |
Why?
|
| Lod Score | 2 | 2003 | 23 | 0.060 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2006 | 14 | 0.060 |
Why?
|
| Blotting, Northern | 2 | 2008 | 152 | 0.060 |
Why?
|
| Glutamate Plasma Membrane Transport Proteins | 1 | 2006 | 1 | 0.060 |
Why?
|
| Early Diagnosis | 1 | 2006 | 92 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 1556 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 572 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 333 | 0.060 |
Why?
|
| Electromyography | 3 | 2016 | 98 | 0.060 |
Why?
|
| Membrane Transport Proteins | 2 | 2018 | 138 | 0.060 |
Why?
|
| Pancreas, Exocrine | 1 | 2005 | 12 | 0.060 |
Why?
|
| Phenylbutyrates | 1 | 2005 | 6 | 0.060 |
Why?
|
| Cricetulus | 1 | 2005 | 103 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2006 | 189 | 0.060 |
Why?
|
| Dyneins | 1 | 2006 | 112 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2019 | 139 | 0.060 |
Why?
|
| Phosphorothioate Oligonucleotides | 1 | 2024 | 10 | 0.060 |
Why?
|
| Biological Transport | 3 | 2016 | 292 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2005 | 414 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 384 | 0.050 |
Why?
|
| Protein Structure, Secondary | 2 | 2003 | 260 | 0.050 |
Why?
|
| Calpain | 1 | 2004 | 7 | 0.050 |
Why?
|
| Caveolins | 1 | 2004 | 7 | 0.050 |
Why?
|
| Powders | 1 | 2004 | 21 | 0.050 |
Why?
|
| Base Pair Mismatch | 1 | 2024 | 36 | 0.050 |
Why?
|
| Creatine | 1 | 2004 | 23 | 0.050 |
Why?
|
| Endosomes | 1 | 2005 | 181 | 0.050 |
Why?
|
| Europe | 3 | 2012 | 199 | 0.050 |
Why?
|
| Cell Aggregation | 1 | 2004 | 21 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2004 | 193 | 0.050 |
Why?
|
| Psychomotor Performance | 2 | 2018 | 136 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2004 | 113 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2021 | 2049 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2004 | 77 | 0.050 |
Why?
|
| Gliosis | 1 | 2024 | 27 | 0.050 |
Why?
|
| CD8 Antigens | 1 | 2004 | 52 | 0.050 |
Why?
|
| Isoxazoles | 1 | 2004 | 14 | 0.050 |
Why?
|
| Antigens, CD34 | 1 | 2004 | 53 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 162 | 0.050 |
Why?
|
| Disulfides | 1 | 2004 | 66 | 0.050 |
Why?
|
| Protein Aggregates | 1 | 2024 | 23 | 0.050 |
Why?
|
| Cell Transplantation | 1 | 2004 | 41 | 0.050 |
Why?
|
| Myelin Sheath | 1 | 2024 | 37 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2004 | 165 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 694 | 0.050 |
Why?
|
| Tacrolimus | 1 | 2004 | 63 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2003 | 78 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2003 | 7 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 1104 | 0.050 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2024 | 88 | 0.050 |
Why?
|
| Neurites | 2 | 2016 | 23 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 185 | 0.050 |
Why?
|
| Gangliosides | 1 | 2023 | 19 | 0.050 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2004 | 87 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 2 | 2014 | 78 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2019 | 6803 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2003 | 10 | 0.050 |
Why?
|
| Hydrolases | 1 | 2024 | 82 | 0.050 |
Why?
|
| CD4 Antigens | 1 | 2004 | 149 | 0.050 |
Why?
|
| Genome, Human | 3 | 2010 | 237 | 0.050 |
Why?
|
| Cellular Senescence | 1 | 2004 | 120 | 0.050 |
Why?
|
| Losartan | 1 | 2022 | 19 | 0.050 |
Why?
|
| Acyltransferases | 1 | 2002 | 32 | 0.050 |
Why?
|
| Particle Size | 1 | 2004 | 428 | 0.050 |
Why?
|
| Spleen | 1 | 2004 | 476 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2004 | 281 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 298 | 0.050 |
Why?
|
| Polyphosphates | 1 | 2022 | 13 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 2483 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2020 | 3299 | 0.050 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2022 | 63 | 0.050 |
Why?
|
| Insecta | 1 | 2002 | 36 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2006 | 1410 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2021 | 12 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 403 | 0.050 |
Why?
|
| Injections, Intraventricular | 2 | 2016 | 23 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2001 | 7 | 0.050 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2002 | 25 | 0.040 |
Why?
|
| Stem Cells | 1 | 2004 | 274 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2022 | 95 | 0.040 |
Why?
|
| Glutamine | 1 | 2021 | 50 | 0.040 |
Why?
|
| Protein Engineering | 1 | 2002 | 84 | 0.040 |
Why?
|
| Oxidopamine | 1 | 2021 | 6 | 0.040 |
Why?
|
| Integrins | 1 | 2021 | 109 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2021 | 216 | 0.040 |
Why?
|
| Anticonvulsants | 1 | 2022 | 103 | 0.040 |
Why?
|
| Kidney | 1 | 2004 | 451 | 0.040 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2002 | 91 | 0.040 |
Why?
|
| Drosophila | 3 | 2012 | 481 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2023 | 479 | 0.040 |
Why?
|
| Cholesterol | 1 | 2021 | 261 | 0.040 |
Why?
|
| Neuronal Plasticity | 1 | 2021 | 152 | 0.040 |
Why?
|
| Biological Specimen Banks | 1 | 2020 | 23 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2004 | 418 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2007 | 706 | 0.040 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2019 | 7 | 0.040 |
Why?
|
| Hippocampus | 1 | 2021 | 274 | 0.040 |
Why?
|
| Acrylamides | 1 | 2019 | 13 | 0.040 |
Why?
|
| Thiazolidines | 1 | 2019 | 14 | 0.040 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2019 | 23 | 0.040 |
Why?
|
| Monocytes | 1 | 2002 | 362 | 0.040 |
Why?
|
| Thiazoles | 1 | 2019 | 45 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 80 | 0.040 |
Why?
|
| Cytoplasm | 2 | 2011 | 282 | 0.040 |
Why?
|
| Heterozygote | 1 | 2019 | 173 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2019 | 115 | 0.040 |
Why?
|
| Macaca | 1 | 2018 | 30 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2018 | 35 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2018 | 46 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2019 | 158 | 0.040 |
Why?
|
| Tunicamycin | 1 | 2018 | 8 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2013 | 623 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2019 | 181 | 0.040 |
Why?
|
| Substrate Specificity | 2 | 2010 | 336 | 0.040 |
Why?
|
| Tryptophan | 1 | 2018 | 56 | 0.030 |
Why?
|
| Protein Domains | 1 | 2019 | 153 | 0.030 |
Why?
|
| Lipids | 2 | 2011 | 326 | 0.030 |
Why?
|
| Conditioning, Operant | 1 | 2018 | 27 | 0.030 |
Why?
|
| Algorithms | 1 | 2003 | 1033 | 0.030 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2018 | 98 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2018 | 61 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2018 | 52 | 0.030 |
Why?
|
| Immunity | 1 | 2018 | 108 | 0.030 |
Why?
|
| Prednisone | 1 | 2018 | 83 | 0.030 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 60 | 0.030 |
Why?
|
| Reaction Time | 1 | 2018 | 127 | 0.030 |
Why?
|
| Locomotion | 1 | 2018 | 114 | 0.030 |
Why?
|
| S100 Calcium Binding Protein A6 | 1 | 2017 | 3 | 0.030 |
Why?
|
| Choice Behavior | 1 | 2018 | 85 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2009 | 373 | 0.030 |
Why?
|
| Polysomnography | 1 | 2017 | 60 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2011 | 371 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 183 | 0.030 |
Why?
|
| Human Embryonic Stem Cells | 1 | 2017 | 38 | 0.030 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2016 | 5 | 0.030 |
Why?
|
| Bronchial Provocation Tests | 1 | 2016 | 17 | 0.030 |
Why?
|
| Organelles | 1 | 2016 | 20 | 0.030 |
Why?
|
| Paralysis | 1 | 2016 | 17 | 0.030 |
Why?
|
| Prions | 1 | 2016 | 27 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 2018 | 174 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2018 | 223 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 1268 | 0.030 |
Why?
|
| Muscle Cramp | 1 | 2016 | 2 | 0.030 |
Why?
|
| Lateral Ventricles | 1 | 2016 | 8 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2018 | 165 | 0.030 |
Why?
|
| Enzyme Stability | 2 | 2007 | 47 | 0.030 |
Why?
|
| Protein Subunits | 2 | 2009 | 169 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2016 | 183 | 0.030 |
Why?
|
| Postural Balance | 1 | 2016 | 67 | 0.030 |
Why?
|
| Intellectual Property | 1 | 2015 | 5 | 0.030 |
Why?
|
| Protein Deglycase DJ-1 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Sequestosome-1 Protein | 1 | 2015 | 8 | 0.030 |
Why?
|
| Turkey | 1 | 2015 | 13 | 0.030 |
Why?
|
| Larva | 1 | 2015 | 158 | 0.030 |
Why?
|
| Genetic Markers | 2 | 2007 | 129 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 2680 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 2015 | 34 | 0.030 |
Why?
|
| Government Regulation | 1 | 2015 | 39 | 0.030 |
Why?
|
| TRPM Cation Channels | 1 | 2015 | 15 | 0.030 |
Why?
|
| Ubiquitins | 1 | 2015 | 41 | 0.030 |
Why?
|
| Smoking | 1 | 2020 | 860 | 0.030 |
Why?
|
| Caspase 3 | 2 | 2006 | 108 | 0.030 |
Why?
|
| Dimerization | 2 | 2005 | 145 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 734 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2016 | 365 | 0.030 |
Why?
|
| Models, Genetic | 2 | 2007 | 266 | 0.030 |
Why?
|
| Receptor, ErbB-4 | 1 | 2013 | 10 | 0.030 |
Why?
|
| Callithrix | 1 | 2013 | 21 | 0.030 |
Why?
|
| Decapodiformes | 1 | 2013 | 14 | 0.020 |
Why?
|
| Cerebrospinal Fluid | 1 | 2013 | 29 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 82 | 0.020 |
Why?
|
| Data Collection | 1 | 2015 | 381 | 0.020 |
Why?
|
| Canada | 1 | 2013 | 152 | 0.020 |
Why?
|
| Synaptic Vesicles | 1 | 2013 | 25 | 0.020 |
Why?
|
| Jews | 1 | 2012 | 10 | 0.020 |
Why?
|
| Growth Cones | 1 | 2012 | 14 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 1555 | 0.020 |
Why?
|
| Transgenes | 1 | 2013 | 197 | 0.020 |
Why?
|
| Superior Cervical Ganglion | 1 | 2012 | 9 | 0.020 |
Why?
|
| Xanthomatosis, Cerebrotendinous | 1 | 2012 | 2 | 0.020 |
Why?
|
| HapMap Project | 1 | 2012 | 5 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2012 | 215 | 0.020 |
Why?
|
| Denervation | 1 | 2012 | 18 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 33 | 0.020 |
Why?
|
| Depression, Chemical | 1 | 2011 | 11 | 0.020 |
Why?
|
| Pain Perception | 1 | 2011 | 5 | 0.020 |
Why?
|
| Survival | 1 | 2011 | 11 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 660 | 0.020 |
Why?
|
| Endocytosis | 1 | 2013 | 153 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 459 | 0.020 |
Why?
|
| Alanine | 1 | 2011 | 50 | 0.020 |
Why?
|
| Oxygen | 1 | 2013 | 317 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2013 | 165 | 0.020 |
Why?
|
| Infertility, Male | 1 | 2011 | 58 | 0.020 |
Why?
|
| Filamins | 1 | 2011 | 8 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2011 | 13 | 0.020 |
Why?
|
| Italy | 1 | 2011 | 69 | 0.020 |
Why?
|
| Recombination, Genetic | 2 | 2003 | 254 | 0.020 |
Why?
|
| Australia | 1 | 2011 | 128 | 0.020 |
Why?
|
| Internationality | 1 | 2010 | 46 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 312 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2010 | 20 | 0.020 |
Why?
|
| United Kingdom | 1 | 2010 | 85 | 0.020 |
Why?
|
| RNA Helicases | 1 | 2011 | 98 | 0.020 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2010 | 14 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 1115 | 0.020 |
Why?
|
| Fumonisins | 1 | 2010 | 2 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 793 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2010 | 46 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2009 | 11 | 0.020 |
Why?
|
| RNA Editing | 1 | 2010 | 24 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 2010 | 30 | 0.020 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2009 | 16 | 0.020 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2009 | 12 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2009 | 17 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2009 | 71 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2012 | 790 | 0.020 |
Why?
|
| Spodoptera | 1 | 2009 | 27 | 0.020 |
Why?
|
| Endoribonucleases | 1 | 2009 | 56 | 0.020 |
Why?
|
| Quality of Life | 1 | 2016 | 1254 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2009 | 260 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2010 | 344 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2009 | 168 | 0.020 |
Why?
|
| CD11c Antigen | 1 | 2008 | 8 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 203 | 0.020 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2008 | 19 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2010 | 204 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2008 | 51 | 0.020 |
Why?
|
| Biological Availability | 1 | 2009 | 208 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2008 | 133 | 0.020 |
Why?
|
| Longevity | 1 | 2009 | 117 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2008 | 147 | 0.020 |
Why?
|
| Cell Separation | 1 | 2008 | 147 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2008 | 138 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2008 | 83 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2008 | 75 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2008 | 102 | 0.020 |
Why?
|
| Family | 1 | 2010 | 245 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2008 | 140 | 0.020 |
Why?
|
| Facial Nerve | 1 | 2008 | 8 | 0.020 |
Why?
|
| Vibrissae | 1 | 2008 | 7 | 0.020 |
Why?
|
| Neurons, Afferent | 1 | 2008 | 17 | 0.020 |
Why?
|
| Ganglia, Spinal | 1 | 2008 | 30 | 0.020 |
Why?
|
| Isoquinolines | 1 | 2008 | 30 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2007 | 20 | 0.020 |
Why?
|
| Siblings | 1 | 2007 | 41 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2007 | 97 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2008 | 87 | 0.020 |
Why?
|
| Synapses | 1 | 2009 | 192 | 0.020 |
Why?
|
| Trinucleotide Repeats | 1 | 2007 | 18 | 0.020 |
Why?
|
| Mammals | 1 | 2009 | 222 | 0.020 |
Why?
|
| Founder Effect | 1 | 2007 | 10 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2011 | 632 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2007 | 89 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2007 | 50 | 0.020 |
Why?
|
| COS Cells | 1 | 2007 | 180 | 0.020 |
Why?
|
| Mesencephalon | 1 | 2006 | 28 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2006 | 35 | 0.020 |
Why?
|
| Dysarthria | 1 | 2006 | 7 | 0.020 |
Why?
|
| Spinal Nerve Roots | 1 | 2006 | 18 | 0.020 |
Why?
|
| Hypesthesia | 1 | 2006 | 8 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2007 | 311 | 0.020 |
Why?
|
| Paresis | 1 | 2006 | 15 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2007 | 138 | 0.020 |
Why?
|
| Polyneuropathies | 1 | 2006 | 12 | 0.020 |
Why?
|
| Cytoplasmic Dyneins | 1 | 2006 | 6 | 0.020 |
Why?
|
| Expressed Sequence Tags | 1 | 2006 | 28 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2006 | 84 | 0.020 |
Why?
|
| Leg | 1 | 2006 | 87 | 0.010 |
Why?
|
| Purkinje Cells | 1 | 2005 | 5 | 0.010 |
Why?
|
| Spinal Diseases | 1 | 2006 | 49 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2005 | 56 | 0.010 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2005 | 7 | 0.010 |
Why?
|
| Dopamine | 1 | 2006 | 108 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2005 | 89 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2005 | 50 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2008 | 533 | 0.010 |
Why?
|
| Microglia | 1 | 2008 | 249 | 0.010 |
Why?
|
| Caspase Inhibitors | 1 | 2005 | 21 | 0.010 |
Why?
|
| Cytochromes c | 1 | 2005 | 28 | 0.010 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2005 | 27 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2005 | 292 | 0.010 |
Why?
|
| Acetylation | 1 | 2005 | 120 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 2005 | 67 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2005 | 85 | 0.010 |
Why?
|
| Oocytes | 1 | 2006 | 201 | 0.010 |
Why?
|
| Premedication | 1 | 2004 | 20 | 0.010 |
Why?
|
| Electron Transport Complex IV | 1 | 2004 | 15 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 2006 | 146 | 0.010 |
Why?
|
| Chromatography, Gel | 1 | 2004 | 63 | 0.010 |
Why?
|
| Curcumin | 1 | 2005 | 82 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 389 | 0.010 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2006 | 220 | 0.010 |
Why?
|
| Dynactin Complex | 1 | 2003 | 7 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2005 | 435 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2003 | 97 | 0.010 |
Why?
|
| Centromere | 1 | 2003 | 45 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2003 | 156 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 298 | 0.010 |
Why?
|
| Histones | 1 | 2005 | 493 | 0.010 |
Why?
|
| Microtubules | 1 | 2003 | 211 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2004 | 394 | 0.010 |
Why?
|